Next Article in Journal
Study Protocol for a Randomized Double Blind, Treatment Control Trial Comparing the Efficacy of a Micronutrient Formula to a Single Vitamin Supplement in the Treatment of Premenstrual Syndrome
Next Article in Special Issue
Compounds from Terminalia mantaly L. (Combretaceae) Stem Bark Exhibit Potent Inhibition against Some Pathogenic Yeasts and Enzymes of Metabolic Significance
Previous Article in Journal
Identification of Phlogacantholide C as a Novel ADAM10 Enhancer from Traditional Chinese Medicinal Plants
Previous Article in Special Issue
Chemical Composition, Cytotoxic, Apoptotic and Antioxidant Activities of Main Commercial Essential Oils in Palestine: A Comparative Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Isolation and Cytotoxic Investigation of Flacourtin from Oncoba spinosa

by
Olaoye S. Balogun
*,
Olukayode S. Ajayi
and
Olayinka S. Lawal
Department of Chemistry, Obafemi Awolowo University, Ile-Ife 220005, Nigeria
*
Author to whom correspondence should be addressed.
Medicines 2016, 3(4), 31; https://doi.org/10.3390/medicines3040031
Submission received: 26 October 2016 / Revised: 23 November 2016 / Accepted: 29 November 2016 / Published: 6 December 2016
(This article belongs to the Special Issue Plant Medicines for Clinical Trial)

Abstract

:
Background: Oncoba spinosa, an endangered medicinal plant whose secondary metabolites have not been extensively profiled, and which is hitherto yet to be examined for cytotoxicity, is being investigated in this study. Methods: Leaves of Oncoba spinosa (800 g) were extracted with 95% aqueous methanol. The crude extract was partitioned with n-hexane and the resultant defatted extract was extensively chromatographed on silica gel to yield compound 1 which was subjected to spectroscopic analysis. A brine shrimps lethality test was used to establish the cytotoxicity potentials of the isolated compound and the plant extracts. Results: Compound 1 was elucidated as flacourtin, 3-hydroxy-4-hydroxymethylphenyl-6-O-benzoyl-β-d-glucopyranoside. The LD50 values obtained were less than 1000 µg/mL for flacourtin and the plant extracts. Conclusion: Flacourtin is being reported for the first time in the O. spinosa. The preliminary toxicity assay indicated that flacourtin and the plant extracts were not cytotoxic; thus, the tradomedicinal uses of the plant may portend no danger.

1. Introduction

O. spinosa is a spiny shrub used for the management of arthritis in southwest Nigeria [1]. The fruit is used for the treatment of anthelminthic, syphilis, wound and sexual impotence [2]. In profiling the chemical constituent of Oncoba spinosa, (Flacourtiaceae) five flavonoids, kaempferol, quercetin, apigenin-7-O-β-d-glucuronopyranoside, quercetin 3-O-β-d-galactopyranoside and quercetin 3-O-α-rhamnopyranosyl (1→6) β-d-glucopyranoside have been reported [3]. Flacourtin, a phenolic glycoside ester (3-hydroxy-4-hydroxymethylphenyl-6-O-benzoyl-β-d-glucopyranoside) which has been associated with a number of pharmacological activities was first isolated from the bark of a medicinal plant, Flacourtia indica (Flacourtiaceae) [4,5,6,7,8], an indigenous medicinal plant widely distributed in India and Bangladesh [9]. Also, Amarasinghe et al. [10] reported isolation of a new glucoside, flacourside, an analog of flacourtin from Flacourtia indica. As part of our on-going work on metabolite profiling of indigenous medicinal plants, leaves of O. spinosa were collected with the aim of isolating a bioactive compound new to the plant specie.

2. Materials and Methods

2.1. Plant Collection and Purification

Fresh leaves Oncoba spinosa were collected at the Botanical Garden University of Ibadan, Oyo State, Nigeria in the month of November, 2014. The plant was identified by the taxonomist and curator, Mr A. Owolabi in the Botanical Garden. A voucher copy of the plant with herbarium number FHI 108806 was deposited at the Forestry Research Institute of Nigeria, Ibadan.
The air-dried and pulverized leaves (800 g) were extracted with 95% aqueous methanol to give a crude extract (140 g). The crude was reconstituted in methanol and defatted with n-hexane to afford 80.60 g of defatted extract. Twenty grams of the defatted extract was chromatographed on silica gel using gradient of dichloromethane and methanol to give a sub-fraction (1.22 g) which was further purified on silica with gradient of hexane, ethyl acetate and methanol. Compound 1 (6 mg) was obtained as an off-white powder which was recrystallized in ethylacetate and thereafter subjected to spectroscopic analysis.

2.2. Cytotoxicity Assay

Cytotoxicity of the crude extract, defatted fraction and compound 1 were investigated using brine shrimp lethality assay. A spoonful quantity of the egg of brine shrimps (Artemia salina Leach) was sprinkled into a partly covered crucible containing seawater in order to allow partial illumination. The eggs hatched into matured nauplii after about 48 h and 10 matured nauplii were added to varying concentration of the test samples (1000, 100 and 10 µg/mL). All the experiments were carried out in triplicate and distilled water was used in place of the test samples for negative control. Numbers of survivors were counted after 24 h and the LC50 was computed at 95% confidence limit using the Finney program.

3. Results

IR νmax (cm−1): 3000 (ArO–H str), 3050 (Ar–H str), 1710 (C=O str), 1600 (Ar C–C str), 1220 (C–O ester), 1053 (C–O alc).
13C-NMR (MeOD, 75 MHz): δc 134.5 (C-1′), 130.7 (C-2′ and C-6′), 129.7 (C-3′ and C-5′), 132 (C-5′), 150.1 (C-1″), 116.3 (C-2″), 154 (C-3″), 134.1 (C-4″), 115.7 (C-5″), 119.7 (C-6″), 61.1 (C-7″), 104.6 (C-1), 75.7 (C-2), 75.2 (C-3), 72.1(C-4), 78.1 (C-5), 64.8 (C-6), 182 (C=O).
1H-NMR (MeOD, 300 MHz): δ 8.05 (2H, m, Jo 7.2 Hz, Jm 1.5 Hz, H-2 and H-6), 7.53 (2H, m, J3,2 7.2 Hz, J3,5 7.8 Hz , H-3 and H-5), 7.66 (1H, m, Jo 7.5 Hz, Jm 1.5 Hz, H-5), 6.77 (1H, d, Jm 3.0 Hz, H-2″), 7.03 (1H, d, Jo 8.7 Hz, H-5″), 6.48 (1H, dd, Jo 8.7 Hz, Jm 3.3 Hz, H-6″), 4.62 (1H, d, H-1), 3.51 (3H, m, H-2, H-3 and H-4), 3.73 (1H, m, J5,6 7.5 Hz, H-5), 4.46 (1H, d, J5,6 7.5 Hz, H-6a), 4.42 (IH, d, J5,6 7.5 Hz, H-6b), 4.72 (H, H-6a″), 4.76 (1H, H-6b″), 4.95, 4.82 and 4.72 (glucose OH), 4.69 (benzylic OH).

4. Discussion

The NMR spectra of compound 1 showed a pattern characteristic of a phenolic ester glycoside. Clusters of peaks at δ 3.5–5.0 indicated the presence of a sugar moiety while the aromatic region showed the presence of eight protons with J values typical of an aromatic system, thus suggesting two substituted benzene rings (Figure 1). The IR spectrum showed absorption bands (cm−1) at 3000 (ArO–H str), 3050 (Ar–H str), 1710 (C=O str), 1600 (Ar C–C str), 1220 (C–O ester), 1053 (C–O alc) and 810 (1,2,4-trisubstituted aromatic). The chemical shift δ 61.1–78.1 ppm in the 13C-NMR spectrum indicated O-linked carbons of the sugar moiety and the carbinol carbon of the phenolic aglycone. The anomeric carbon and the carbonyl of ester resonated at δ 104.6 and 182 ppm respectively while the aromatic carbons were observed at δ 115.7–150.1 ppm. The spectrum of 1H NMR indicated a multiplet at δ 3.50 assignable to three methine protons on the glucose moiety and two doublets of carbinol protons at δ 4.46 (1H, d, J5,6 7.5 Hz) and δ 4.42 (IH, d, J5,6 7.5 Hz) coupling with H-5 at δ 3.73 ppm (1H, m, J5,6 7.5 Hz). The anomeric proton appeared as a doublet at δ 4.62 ppm indicating an axial position to the pyranose ring.
Three aromatic protons of ring B with J values attributable to a 1,2,4-trisubstituted aromatic system showed at δ 7.03, 6.77 and 6.48. The two protons each at ortho and meta position in ring A are in the same chemical environment, thus both protons at ortho position resonated at δ 8.05 with Jo and Jm of 7.2 and 1.5 Hz respectively. Similarly, symmetrical protons at meta positions were observed at δ 7.53 with coupling constant of 7.2 and 7.8 Hz, showing that the protons were doubly ortho-coupled, which connoted that ring A is monosubstituted. All the spectroscopic data and their assignments were in good agreement with the report of Bhaumik et al. [4]. The compound (Figure 1), which was isolated for the first time from leaves of O. spinosa, was elucidated as 3-hydroxy-4-hydroxymethylphenyl-6-O-benzoyl-β-d-glucopyranoside, previously named flacourtin.
The brine shrimps lethality test indicated that crude extract, methanol fraction and flacourtin had LD50 values greater than 1000 µg/mL (Table 1) which implied that they exhibited no cytotoxic activity on the nauplii.

5. Conclusions

Flacourtin is being reported for the first time in the O. spinosa. The preliminary toxicity profile as indicated by brine shrimp lethality test showed that the compound and the plant extracts were not cytotoxic; therefore, the tradomedicinal uses of the plant may portend no danger.

Author Contributions

Olaoye S. Balogun conceived and designed the experiment with Olukayode S. Ajayi while Lawal S. Olayinka performed the experiment.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gbadamosi, I.T.; Oloyede, A.A. Mineral, proximate and phytochemical components of ten Nigeria medicinal plants used in the management of arthritis. Afr. J. Pharm. Pharmacol. 2014, 8, 638–643. [Google Scholar] [CrossRef]
  2. Ramzi, A.; Mothana, A.; Kriegisch, S.; Harms, M.; Kristian, W.; Landequist, U. Assessment of Yemeni medinal plant for their in vitro antimicrobial, anticancer, and antioxidant activities. J. Pharm. Biol. 2011, 49, 200–210. [Google Scholar]
  3. Djoussi, M.G.; Jean, D.M.; David, N.; Jules, R.K.; Leon, A.T.; Dominique, H.; Laurence, V.N. Antimicrobial and antioxidant flavonoids from the leaves of Oncoba spinosa. BMC Complement. Altern. Med. 2005, 15, 134. [Google Scholar] [CrossRef] [PubMed]
  4. Bhaumik, P.K.; Guha, K.P.; Biswas, G.K.; Mukherjee, B. (−)Flacourtin, a phenolic glucoside ester from Flacourtia indica. Phytochemistry 2005, 26, 3090–3091. [Google Scholar] [CrossRef]
  5. Nazneen, M.; Mazid, M.A.; Kundu, J.K.; Bachar, S.C.; Begum, F.; Datta, B.K. Protective effects of Flacourtia indica aerial parts extracts against paracetamol-induced hepatotoxiciy in rats. J. Taibah Univ. Sci. 2009, 2, 1–6. [Google Scholar] [CrossRef]
  6. Saxena, A.; Patel, B.D. In vitro antioxidant activity of methanolic and aqueous extract of Flacourtia indica Merr. Am.-Eurasian J. Sci. Res. 2010, 5, 201–206. [Google Scholar]
  7. Singh, T.S.; Singh, M.; Yadav, D.; Singh, I.; Mansoori, M.H. Antiasthmatic potential of Flacourtia indica Merr. Afr. J. Basic Appl. Sci. 2011, 3, 201–204. [Google Scholar]
  8. Eramma, N.; Gayathri, D. Antibacterial potential and phytochemical analysis of Flacourtia indica (Burm.f.) Merr. root extract against human pathogens. Indo Am. J. Pharm. Res. 2013, 3, 3832–3846. [Google Scholar]
  9. Patro, S.K.; Behera, P.C.; Kumar, P.M.; Sasmal, D.; Padhy, R.K.; Dash, S.K. Pharmacological Review of Flacourtia sepiaria (Ruxb.). Sch. Acad. J. Pharm. 2013, 2, 89–93. [Google Scholar]
  10. Amarasinghe, N.R.; Jayasinghe, L.; Hara, N.; Fujimoto, Y. Flacourside, a new 4-oxo-2-cyclopentenylmethyl glucoside from the fruit juice of Flacourtia indica. Food Chem. 2007, 102, 95–97. [Google Scholar] [CrossRef]
Figure 1. Flacourtin.
Figure 1. Flacourtin.
Medicines 03 00031 g001
Table 1. Cytotoxicity of test samples.
Table 1. Cytotoxicity of test samples.
SampleCruden-Hexane FractionDefatted FractionFlacourtin
LD50 (µg/mL)1203>10,000>10,000>10,000

Share and Cite

MDPI and ACS Style

Balogun, O.S.; Ajayi, O.S.; Lawal, O.S. Isolation and Cytotoxic Investigation of Flacourtin from Oncoba spinosa. Medicines 2016, 3, 31. https://doi.org/10.3390/medicines3040031

AMA Style

Balogun OS, Ajayi OS, Lawal OS. Isolation and Cytotoxic Investigation of Flacourtin from Oncoba spinosa. Medicines. 2016; 3(4):31. https://doi.org/10.3390/medicines3040031

Chicago/Turabian Style

Balogun, Olaoye S., Olukayode S. Ajayi, and Olayinka S. Lawal. 2016. "Isolation and Cytotoxic Investigation of Flacourtin from Oncoba spinosa" Medicines 3, no. 4: 31. https://doi.org/10.3390/medicines3040031

APA Style

Balogun, O. S., Ajayi, O. S., & Lawal, O. S. (2016). Isolation and Cytotoxic Investigation of Flacourtin from Oncoba spinosa. Medicines, 3(4), 31. https://doi.org/10.3390/medicines3040031

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop